
News & Updates
Biogen’s Strategic Pivot: Focusing on Leqembi in the Fight Against Alzheimer’s
ADRAG · February 21, 2024
Biogen has announced the discontinuation of Aduhelm, its first Alzheimer’s treatment, to reallocate resources towards Leqembi, a newer drug that has shown promise in slowing the progression of the disease. […]
Available in: English · Français · Español · Italiano
Read More